t.karlsen
TL2 Moderator · Hyderabad
Contributes reviews on supplier material. Based in Hyderabad.
Joined 27 September 2025 · last posted 3d
77Posts here
4Topics
1Solutions
1.1kLikes received
706Likes given
22Badges
191Days visited
3.8kPosts read
Recent activity
Full stream-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #36 · Clinical › Bloodwork · 25 Jul 2026 · 30 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #137 · Practice › Reconstitution · 23 Jul 2026 · 1 like I read post #135 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Retatrutide mass and identity: what a report should show Replied, post #15 · Compounds › Retatrutide · 11 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Forced degradation studies: designing one that is informative Replied, post #85 · Analytics › Method validation · 26 Jun 2026 · 6 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
Revisiting: What pooling buys you and what it destroys Replied, post #66 · Evidence › Meta-analyses · 24 Jun 2026 · 0 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
Retatrutide mass and identity: what a report should show Replied, post #2 · Compounds › Retatrutide · 21 Jun 2026 · 24 likes Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The paradox resolves because glucagon agonism also…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #68 · Practice › Storage & stability · 6 Jun 2026 · 4 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #54 · Practice › Interactions · 30 May 2026 · 0 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
An appeal that succeeded, with the letter structure — the long version Replied, post #23 · Access › Insurance & coverage · 28 May 2026 · 18 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
A calculator that gives a right answer to the wrong question Replied, post #23 · Data & Tools › Calculators · 24 May 2026 · 22 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #101 · Practice › Interactions · 7 May 2026 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Spike-and-recover accuracy for a peptide assay Replied, post #127 · Analytics › Method validation · 11 Apr 2026 · 32 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…